Long elimination half-life of idraparinux may explain major bleeding and recurrent events of patients from the van Gogh trials (Q46722044)
Jump to navigation
Jump to search
scientific article published on 27 February 2008
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Long elimination half-life of idraparinux may explain major bleeding and recurrent events of patients from the van Gogh trials |
scientific article published on 27 February 2008 |
Statements
1 reference
Long elimination half-life of idraparinux may explain major bleeding and recurrent events of patients from the van Gogh trials (English)
1 reference
1 reference
1 reference
Y Vukojevic
1 reference
I Joerg
1 reference
C Weiss
1 reference
27 February 2008
1 reference
6
1 reference
5
1 reference
890-892
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
Identifiers
1 reference